Page 100 - Sohini Das

Govt allows import of superior testing technologies in Covid-19 battle

Players like Abbott, Roche, Trivitron, Eris get approvals to import chemiluminescent kits, ELISA kits too get nod

In race to stop Covid-19, Indian drugmakers to conduct clinical trials

Glenmark, Zydus Cadila to start trials in May

Chemists not to sell cold, flu medicines without valid prescriptions

Around five states asked medical shops to keep a record of patients who buy medicines for fever, cough and cold

Covid-19 spread: Makers of RT-PCR kits boost production as rapid tests fail

With imports getting stringent, indigenous players like MyLab and CoSara Diagnostics are seeing a rise in enquiries from state and Central govts and private laboratories alike

MyLab starts making RNA extraction kits for crucial Covid-19 test

There is a huge shortage in India of these kits, which are critical in extracting sufficient quantities of RNA for accurate molecular diagnosis

Covid-19 lockdown: Domestic pharma growth takes hit as stock piles up

Inventory days have gone up from 31 days as on March 22 to 41 days as on April 22

Coronavirus outbreak: India cancels Chinese rapid antibody test kit orders

ICMR cancels Wondfo's test kits; row on prices and efficacy erupts

India to test 100-yr-old vaccine on adults as war on Covid-19 hots up

The 100-yr old vaccine has an established safety profile; if effective, it can hit the market within this year

Lockdown hits production of anti-TB drugs, health min seeks to ban export

In a letter to various departments, the health ministry has said the "situation calls for extraordinary measures" to make sure that TB patients do not face challenges in diagnosis or treatment.

ICMR begins trials on Covid-19 patients to test plasma therapy's efficacy

Plan is to have 20-25 such trials across India under the apex health research institute

Mumbai ramps up testing to three-fold to 4,000 samples a day

Starts door-to-door screening in Worli and Dharavi; 81% tested in Maharashtra are asymptomatic; BMC awaits rapid antibody test kits; isolation centres, Covid-19 beds being added rapidly

Cadila Healthcare at the forefront, looks at biologic drug to treat Covid

Company is already working on developing 2 vaccine candidates, diagnostic kits and also making HCQ

How Mumbai admin is battling coronavirus as cases continue to spike

The city administration is trying to ramp up the isolation and treatment center capacities here as cases continue to spike

Indian pharma majors step in to develop, import coronavirus test kits

The rapid test uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein

Govt allows imported drugs with residual shelf life of under 60%

Relaxes norms as cargo stuck at ports makes it difficult for consignments to be released expeditiously, subject to written request from importer

Coronavirus outbreak: India plans ayurvedic trials on patients soon

On the preventive front, many states, including Haryana, Goa and Kerala, have started using ayurvedic medicines for asymptomatic patients and even frontline workers.

Covid-19 impact: Pharma players join hands to ensure smooth production

Combined capacity utilisation at all-India level is 60-70% - higher than in most other industries

Covid-19 impact: Hydroxychloroquine's share in pharma exports minuscule

Manufacturers say there is enough stock for local needs

Coronavirus outbreak: Pharma market grows 9% in March due to panic buying

Cardio-diabetic and respiratory segments clock robust growth

Coronavirus impact: Ipca, Cadila Healthcare stocks gain on India's HCQ move

Apart from the US, Brazil and Sweden have requested for the drug to battle the Covid-19 scare in their countries.